Suspend circulation of two drugs that do not meet quality standards
The Drug Administration has just announced the suspension of circulation of two types of capsules Euroseafox and Cefaclor.
The Hanoi Department of Health has just sent a document to public health facilities under the sector and non-public health facilities in the area requesting the suspension of circulation of two types of capsules Euroseafox and Cefaclor that do not meet quality standards.
Previously, the Hanoi Department of Health received a dispatch from the Drug Administration of Vietnam (Ministry of Health) announcing the suspension of circulation of the two drugs mentioned above due to not meeting quality standards regarding solubility.
Euroseafox capsules have registration number: VN-12288-11, batch number: 03, production date: June 9, 2013, expiration date: June 9, 2016, manufactured by a company in Bangladesh and imported by the branch of Vimedimex Pharmaceutical Joint Stock Company in Hanoi. This drug sample was taken at Viet Anh Pharmaceutical Company Limited (counter 212, 2nd floor, building 24T1 (Hapulico) - No. 1 Nguyen Huy Tuong, Thanh Xuan, Hanoi. Cefaclor capsules have registration number: VD-10807-10, batch number: 0112, production date: November 29, 2012, expiry date: November 29, 2015. The drug is manufactured by Pharmaceutical and Medical Biological One Member Limited Liability Company (Mebiphar). This drug sample was taken at Trang Vinh Pharmaceutical Joint Stock Company (counter 512, 5th floor, building 24T1 (Hapulico) - No. 1 Nguyen Huy Tuong, Thanh Xuan, Hanoi./.
According to Vov
